-
3001
-
3002
Severe late onset capillary leak syndrome post allo-HSCT successfully treated by bevacizumab: a case report
Published 2025-01-01“…Capillary leak syndrome (CLS) represents a critical complication arising from allogeneic hematopoietic stem cell transplantation (allo-HSCT). The prognosis for CLS remains considerably constrained. …”
Get full text
Article -
3003
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
Published 2024-01-01“… We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to allogeneic stem cell transplantation. Valemetostat led to a quick response and was well tolerated, offering as a promising bridge therapy to transplantation for patients with relapsed/refractory peripheral T-cell lymphoma which is still an unmet medical need. …”
Get full text
Article -
3004
Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model
Published 2025-01-01“…We investigated gut microbiota dynamics in a nonhuman primate (NHP) cardiac ischemia/reperfusion model while under immunosuppression and receiving cell therapy with human induced pluripotent stem cell (hiPSC)-derived endothelial cells (EC) and cardiomyocytes (CM). …”
Get full text
Article -
3005
Anti-Stemness and Anti-Proliferative Effects of Cadmium on Bovine Mammary Epithelial Cells
Published 2024-12-01“…Our study uncovers a previously unrecognized role of cadmium in mammary cell stemness and suggests that cadmium may affect breast development by impairing normal stem cell self-renewal and inducing their apoptosis. …”
Get full text
Article -
3006
Integrating Bulk and Single-Cell Transcriptomic Data to Identify Ferroptosis-Associated Inflammatory Gene in Alzheimer’s Disease
Published 2025-02-01“…Huiqin Zhou,1– 3,* Yunjia Peng,2,3,* Xinhua Huo,2,3 Bingqing Li,2,3 Huasheng Liu,4 Jian Wang,3,5 Gaihua Zhang1 1College of Life Sciences, Hunan Normal University, Changsha, People’s Republic of China; 2Hunan Guangxiu Hospital, Hunan Normal University, Changsha, People’s Republic of China; 3National Engineering Center of Human Stem Cell, Changsha, People’s Republic of China; 4Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 5The Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Sciences, Central South University, Changsha, People’s Republic of China*These authors contributed equally to this workCorrespondence: Gaihua Zhang, The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, China. …”
Get full text
Article -
3007
Regulatory Immunotherapy in Bone Marrow Transplantation
Published 2011-01-01“…Every year individuals receive hematopoietic stem cell transplantation (HSCT) to eradicate malignant and nonmalignant disease. …”
Get full text
Article -
3008
-
3009
-
3010
Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration?
Published 2013-01-01“…Second cancers and particularly postransplant lymphoproliferative disorders (PTLDs) are extremely rare in patients undergoing autologous peripheral blood stem cell transplantation (auto-SCT). We report the case of clonally rearranged T-cell expansion which occurred after auto-SCT for Multiple Myeloma (MM). …”
Get full text
Article -
3011
Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
Published 2015-01-01“…Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6 months and most cases present within 2 years after aHSCT. …”
Get full text
Article -
3012
-
3013
Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation
Published 2021-01-01Get full text
Article -
3014
Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease
Published 2018-01-01“…Although the pathogenesis remains unclear, this association probably reflects an incidental and fortuitous finding rather than the alteration of a common pluripotent stem cell precursor. Herein, we report on one case of MCD coexisting with CMML and elucidate the underlying mechanism of pathology in some aspects.…”
Get full text
Article -
3015
Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass
Published 2017-01-01“…Posttransplant lymphoproliferative disease is a serious complication following stem cell and solid organ transplantation. Early recognition of the disease is important in facilitating timely therapy and improving long-term outcomes. …”
Get full text
Article -
3016
MATHEMATICAL MODEL OF PHYTOHORMONE REGULATION OF ROOT MERISTEMATIC ZONE FORMATION
Published 2015-01-01“…The apical meristem located at the root tip of a plant is one of the most convenient objects to study the organization of the stem cell niche. In the root apical meristem, mitotically inactive cells of the quiescent center coexist with intensely dividing cells, which lose this ability at a certain distance from the quiescent center. …”
Get full text
Article -
3017
GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE
Published 2023-04-01“…The recognition of a germline mutation in a patient affected by a hematologic malignancy allows for a tailored treatment approach in order to minimize toxicities, and informs the donor selection for hematopoietic stem cell transplantation as well as the comorbidities evaluation and surveillance strategies. …”
Get full text
Article -
3018
ChromaFold predicts the 3D contact map from single-cell chromatin accessibility
Published 2024-11-01Get full text
Article -
3019
Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
Published 2024-12-01“…The current standard treatments for AML include chemotherapy and hematopoietic stem cell transplantation. However, chemotherapy suffers from high toxicity and a shortage of hematopoietic stem cell donors, which significantly shortens patient survival. …”
Get full text
Article -
3020
Anesthetic Management of a Child with Mitochondrial Neurogastrointestinal Encephalopathy
Published 2015-01-01“…She had multiple anesthetics while undergoing allogeneic hematopoietic stem cell transplantation. This case report will discuss the successful repeated use of the same anesthetic in this pediatric patient, with the avoidance of volatile anesthetic agents, propofol, and muscle relaxant.…”
Get full text
Article